Sort
21,453 grants matching “tuberculosis”
Modulation of Host Responses by Mycobacterium Tuberculosis
$435,600Jyothi Rengarajan · Emory University · R01 · FY2011 · AI
Longitudinal Study of HIV and Aging in Brazil
$435,598Jessica L Castilho · Vanderbilt University Medical Center · R01 · FY2023 · AG
The role of Esx-3 in mediating drug resistance
$435,250Tanya Parish · Access To Advanced Health Institute · R01 · FY2018 · AI
Human airway microfold cells in mucosal immunity to bacterial pathogens
$435,178Michael Shiloh · Ut Southwestern Medical Center · U01 · FY2019 · AI
Novel Class of Phospholipases-Molecular Pathogenesis
$435,017University Of Colorado Denver · R01 · FY2005 · HL
Mechanistic aspects of the final step of heme b biosynthesis in Gram-positive bacteria
$435,000Gudrun Susanne Lukat-Rodgers · North Dakota State University · R15 · FY2019 · GM
Discovery of inhibitors that target the Mtb ClpP1P2 protease
$434,878Eric Joseph Rubin · Global Alliance For Tb Drug Development · U19 · FY2021 · AI
Discovery of inhibitors that target the Mtb ClpP1P2 protease
$434,877Eric Joseph Rubin · Global Alliance For Tb Drug Development · U19 · FY2023 · AI
Johns Hopkins HIV Epidemiology and Prevention Sciences Training Program
$434,832Chris Beyrer · Johns Hopkins University · T32 · FY2019 · AI
A computer simulation of the Sub-Saharan HIV pandemic that can estimate benefit a
$434,639Ronald Scott Braithwaite · New York University School Of Medicine · R01 · FY2011 · AA
Project 4: Biophysics of Mtb droplets and fluid spray technology to elucidate Mtb transmission
$434,455Lydia Bourouiba · Weill Medical Coll Of Cornell Univ · P01 · FY2024 · AI
SIV/MYCOBACTERIUM COINFECTION
$434,438Beth Israel Deaconess Medical Center · R01 · FY2002 · RR
Host &Pathogen Determinants of M tuberculosis Latency
$434,260Public Health Research Institute · R01 · FY2004 · AI
PK-PD of combination antituberculosis therapy for suppression of drug-resistance
$434,222Tawanda Gumbo · Ut Southwestern Medical Center · R01 · FY2011 · AI
The Asia-Pacific HIV Observational Database (APHOD)
$434,210David A Cooper · Foundation For Aids Research · U01 · FY2010 · AI
The role of Listeria cyclic-di-AMP during infection and immunity
$434,193Daniel A Portnoy · University Of California Berkeley · P01 · FY2015 · AI
Role of lipid mediators in host resistance to Mycobacterium tuberculosis
$434,158Heinz Gernot Remold · Brigham And Women'S Hospital · R01 · FY2011 · AI
White Plague: A Historical Ethnography of Tuberculosis Among Yup'ik Peoples of Southwestern Alaska
$434,151Linda B Green · University Of Arizona · · FY2004 · GEO
Project 3: Negative regulation of type I interferons during bacterial infection
$434,094Russell E Vance · University Of California Berkeley · P01 · FY2024 · AI
Project 3: Negative regulation of type I interferons during bacterial infection
$434,093Russell E Vance · University Of California Berkeley · P01 · FY2023 · AI
Mechanisms of Mycobacterial Antigen Processing
$434,064Chinnaswamy Jagannath · University Of Texas Hlth Sci Ctr Houston · R01 · FY2011 · AI
In Vitro Screening Core
$433,872Nancy Day Connell · Rbhs-New Jersey Medical School · U19 · FY2016 · AI
MYOCOBACTERIAL CELL WALL AND DRUG DISCOVERY
$433,822Colorado State University-Fort Collins · R37 · FY2001 · AI
Studies of Inherited Causes of Fungal Susceptability
$433,819Sergio Rosenzweig · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Rapid Research for Diagnostics Development in TB Network: Episode 2 (R2D2 TB Network II)
$433,790Payam Nahid · University Of California, San Francisco · R01 · FY2025 · AI